🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Drug Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could result in users injecting products of unknown origin.

Some experts stated the popularity for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Material Elimination

Based on the social media company, the platform has removed violative material and prohibited associated keywords and search suggestions. The company said it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, populated with images of weight loss, glowing reviews and step-by-step guides for preparing or injecting at home.

Within minutes of entering one community, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and guaranteed shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, messages display black plastic packages with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has previously encountered individuals injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly serious medical dangers”.